UiPath, Inc. Class A (PATH) Covered Calls

UiPath, Inc. Class A covered calls NuPathe Inc is abiopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders.

You can sell covered calls on UiPath, Inc. Class A to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for PATH (prices last updated Mon 4:16 PM ET):

UiPath, Inc. Class A (PATH) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
11.43 -0.11 11.44 11.50 10.6M 72 6.6
Covered Calls For UiPath, Inc. Class A (PATH)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Jun 21 11.5 0.13 11.37 1.1% 80.3%
Jul 19 11 0.77 10.73 2.5% 27.7%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

NuPathe Inc. is a biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders. Its primary product, Zecuity (sumatriptan iontophoretic transdermal) for the acute treatment of migraine, with or without aura, in adults. The company also has two pipeline product candidates, NP201 for the continuous symptomatic treatment of Parkinson's disease, and NP202 for the long-term treatment of schizophrenia and bipolar disorder using its proprietary long acting delivery biodegradable implant technology. NuPathe was founded by Terri B. Sebree and Jane H. Hollingsworth on January 7, 2005 and is headquartered in Malvern, PA.